| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102382
Status
Published
Date of creation
2011-09-29 13:52 UTC (hana_jirakova@env.cz)
Date of publication
2011-09-29 13:52 UTC (hana_jirakova@env.cz)

Origin of report
Country
  • Czech Republic
Contact officer for report
Coordinates
Hana Jirakova
Cartagena Protocol on Biosafety National Focal Point
Ministry of the Environment of the Czech Republic (MoE)
Vrsovicka 65
Prague
Czech Republic, 10010
Phone:+420 267 122-066
Fax:+420 267 310-013
Email:hana.jirakova@mzp.cz
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
1. Czech Commission for Genetically Modified Organisms and Genetic Products (representatives of the Central Institute for Supervising and Testing in Agriculture, Czech University of Agriculture, State Phytosanitary Administration, University of South Bohemia - Faculty of Science were consulted);
2. Crop Research Institute - National Reference Laboratory for GMO Identification and DNA Fingerprinting;
3. Czech Environmental Inspectorate;
4. Ministry of Agriculture;
5. Customs Administration of the Czech Republic
Submission
10. Date of submission
2011-09-29
11. Time period covered by this report
Start date
2007-10-01
Time period covered by this report
End date
2011-09-30
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is fully in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more national biosafety regulations
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 5
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country:
The legislative framework of the Czech Republic - a member of the European Union - has been harmonised with the European Union  legislation. The European legislation is listed and described in the parallel 2nd National Report of the European Union.

In the Czech Republic, the basic national legal instrument concerning use of GMOs is the Act No. 78/2004 Coll., on the Use of Genetically Modified Organisms and Genetic Products, as amended, with an implementing Decree No. 209/2004. The Act transposes EU Directives 2001/18/EC and 2009/41/EC, therefore it covers the contained use, deliberate release of GMOs into the environment (i.e. field trials) and placing on the market of GMOs as or in products. It has been in force since February 2004.

The EC Regulations 1829/2003, 1830/2003 concerning authorisation of GM food and feed, traceability and labelling of GMOs and GM food and feed, Regulation 1946/2003 implementing the Cartagena Protocol and Regulation 619/2011 laying down the methods of sampling and analysis for the official control of feed as regareds presence of GM material have been directly applicable in the Czech Republic since its accession to the EU in May 2004.

General rules on the co-existence of genetically modified crops with conventional and organic farming are set by the Act 252/1997 Coll., on Agriculture, as amended and specified by the Decree 89/2006, as amended by its implementing Decree 58/2010, on detailed conditions for growing of genetically modified variety.

State administration:
The Competent Authority handling the notifications and regulating the use of GMOs in the Czech Republic is the Ministry of the Environment of the Czech Republic (Competent Authority under EU Directives 2001/18/EC and 2009/41/EC). It co-operates with the Ministry of Health as regards risks for human health and with the Ministry of Agriculture as the agricultural risk, animal health, crops and feeds are concerned.
An expert advisory body to the Ministry of the Environment is the Czech Commission for the Use of GMOs and Genetic Products that consists of scientists, representatives of administrative authorities and NGOs.
The Ministry of the Environment is the Competent Authority and the focal point for the Cartagena Protocol on Biosafety and for the EC Regulation No 1946/2003 as well.
The Competent Authority on state supervision of the use of GMOs is the Czech Environmental Inspectorate. It co-operates with other state supervision bodies in fulfilling this task.
The Ministry of Agriculture of the Czech Republic is the Competent Authority under EC Regulation 1829/2003 on genetically modified food and feed. It also sets down the rules of coexistence.
More information can be retrieved from the Czech national node of the BCH at http:http://www.mzp.cz/biosafety
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • Yes
23. If you answered Yes to question 22, has this information been submitted to the BCH?
  • Yes
24. Here you may provide further details on the implementation of Article 5 in your country:
EU pharma legislation provides that a medicinal product may only be placed on the market in the EU if it has received a marketing authorisation, granted either by the Commission or by a member state. As regards medicinal products containing or consisting of GMOs, the assessment for a marketing authorisation must include an environmental risk assessment in line with the requirements of Directive 2001/18/EC. Regulation 1946/2003 mirrors the provisions of the Protocol as regards exports of pharmaceuticals. 
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • Yes
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • Yes
28. Here you may provide further details on the implementation of Article 6 in your country:
- Contained use:
Act 78/2004 Coll., on the Use of Genetically Modified Organisms and Genetic Products, as later amended, and its implementing Decree 209/2044, on Detailed Conditions for the Use of Genetically Modified Organisms and Genetic Products, as amended, transpose Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms.

- Transit:
Act 78/2004 Coll., on the Use of Genetically Modified Organisms and Genetic Products, as later amended and its implementing Decree 209/2044, on Detailed Conditions for the Use of Genetically Modified Organisms and Genetic Products, as amended, apply also for export, import and transit of GMOs and genetic products.
Regulation 1946/2003 that is directly applicable in the Czech Republic adddresses transboundary movement of GMOs, and specifically requirements for exports of GMOs to third countries as well as for unintentional transboundary movements. According to Article 13 of the Regulation 1946/2003, the exporter shall ensure notification of the transit of GMOs through their territory and have informed the BCH of this decision.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • Yes
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • Yes
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • Yes
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • Yes
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
39. If you answered Yes to question 38, how many LMOs has your country approved to date for import for intentional introduction into the environment?
  • None
40. If you answered Yes to question 38, how many LMOs, not imported, has your country approved to date for intentional introduction into the environment?
  • More than 10
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
Question 33: Central Institute for Supervising and Testing in Agriculture, State Phytosanitary Administration and Czech Environmental Inspection among other activities monitor potential effects of GMOs released into the environent (field trials as well as commercial release). More information on monitoring activities in the Czech Republic can be retreived from the Czech node of the BCH at http://www.mzp.cz/biosafety.

Question 34: Capacity to detect and identify GMOs is sufficient in the Czech Republic. However, more financial means would even strengthen these activities. Contractual laboratories of the Ministry of the Environment are as follows:
▪ Reference Laboratory for Identification of GMOs, Crop Research Institute
▪  Accredited Laboratory of the Department of Biochemistry and Microbiology, Institute of Chemical Technology
▪ National Institute of Public Health - Department for Food Safety and Applied Nutrition
More information can be retreived from the Czech node of the BCH http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/national_contacts.htm

Questions 37-42: The EU applies its domestic legislative framework instead of the Protocol's advanced informed agreement procedure. This framework is compatible with the provisions of the Protocol. The EU domestic legislative framework is built on a range of legislative measures described above and in the parallel EU 2nd National Report.

Notifications on placing GMO on the market are processed differently from applications for deliberate release of GMO into the environment for experimental purposes in the Czech Republic. A company intending to market a GMO in the EU for intentional introduction into the environment must first obtain an authorisation to this end. The authorisation procedure for placing the GMO on the market involves all Member States, as authorised products are granted free movement througout the territory of the EU. The so-called "notification" or "application" submitted by the interested company must include a full evaluation of potential risks to human and animal health and to the environment. It is only after this decision is finally adopted on the basis of a prior risk assessment that the company can proceed with the marketing of the GMO in the EU.
A person who wishes to release GMOs into the environment for experimental purposes in the Czech Republic must first obtain written authorisation from the Czech  compentent national authority. Hence, the authorisation procedure is simpler than the one referred above. The authorisation is given on the basis of an assessment of the risks presented by the GMO -or GMOs- for the environment and human and animal health.  The Czech Republic has issued more than 10 decisions on deliberate release of GMOs into the environment for experimental pursposes, not imported, in the current reported period. More information on the field trials in the Czech Republic can be retrieved from the Czech node of the BCH at http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/acts_regulations_guidelines.html and http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/decisiones.html

Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • Yes
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • No
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • Yes
58. How many LMOs-FFP has your country approved to date?
  • More than 10
59. In the current reporting period, how many decisions has your country taken regarding the import of LMOs-FFP?
  • More than 10
60. In the current reporting period, how many decisions has your country taken regarding domestic use, including placing on the market, of LMOs-FFP?
  • More than 10
61. Has your country informed the Parties through the BCH of its decision(s) regarding import, of LMOs-FFP?
  • Yes, always
62. Has your country informed the Parties through the BCH of its decision(s) regarding domestic use, including placing on the market, of LMOs-FFP within 15 days?
  • Yes, always
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
The Czech Republic follows the EU comprehensive legal framework on GMOs, which also addresses the import of GMOs intended for direct use for food or feed, or for processing. The EU has declared with reference to Article 14.4 of the Cartagena Protocol that it relies on its existing legislative framework for intentional movements of GMOs within the EU and for imports of GMOs into the EU.
With regard to the decisions taken for placing on the market of LMOs-FFP, it has to be noted that those dicisions are taken for the whole European territory nad not by its Member States individually. Therefore all those decisions are subsequently published in the European Biosafety Clearing-House (BCH) and not in the individual Member States' BCHs.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • Yes
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
The CZ has not made use of the implified procedure for imports of LMOs as specified in Article 13. 
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
The Czech Republic has not entered into any bilateral, regional or multilateral agreements or arrangements as per Article 14(1).

The EU has determined as per Article 14(4) and 9 (2) (c) that it relies on its existing legislative framework for intentional movements of GMOs within the EuropeanUnion and for imports of GMOs into the European Union. This decision has been communicated to other Parties through the EU BCH.                                                                                         
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • Yes
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • Yes
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • Yes
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • Yes
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • Yes
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Yes, always
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • Yes, always
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • More than 10
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Yes, always
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Yes, always
93. Here you may provide further details on the implementation of Article 15 in your country:
The EU domestic legal framework, based on a prior risk assessment before authorisation is given, is applicable in the Czech Republic. The notification provided by the company intending to market a GMO must include a full risk assessment of the risks to human and animal health and to the environment, which is assessed by the European Food Safety Authority (EFSA), with an active involvement of Member States, notably as regards the authorisation of GMOs for placing on the market incl. cultivation, where they carry out the intial risk assessment. The overarching aim of the environmental risk assessment is, on a case-by-case basis, to identify and evaluate potential adverse effects of the GMO, both direct and indirect, immediate or delayed, on human health and the environment. The parallel EU 2nd national report includes further details about principles and goals of the environmental risk assessment in the EU that are binding also for the Czech Republic.
In the current reporting period, the Czech Republic has assessed the environmental risk assessment of GM maize MON-ØØØ21-9 as a part of the European authorization procedure for placing above mentioned GM maize on the market incl. cultivation under the Regulation (EC)1829/2003.

In addition, the Czech Republic also carried out risk assessment of GM plants to be released under the field trial conditions on its territory (more than 10 decisions in the current reporting period). More information on the authorization procedure can be retrieved from the Czech node of the BCH at: http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/acts_regulations_guidelines.html (document "Information for notifiers about field trials")

Ministry of Agriculture in close cooperation with its advisory body - the Scientific Committee for Genetically Modified Food and Feed - regularly participated in the European authorization procedure for genetically modified crops intended for direct use as food or feed, or for processing, under the Regulation 1829/2003.
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes
94.2) LMOs intended for direct use as food or feed, or for processing?
  • Yes
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • Yes
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • Yes
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • Yes
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
The European legislative framework, which is binding also for the Czech Republic,  provides that the environmental risk assessment described under question 93 should be conducted with a view to identifying if there is a need for risk management and if so, the most appropriate methods to be used as well as a risk management strategy to be defined. In cases of limited data availability particular appropriate risk management has to be considered to prevent adverse effects on human health and the environment.
As regards national risk management strategies, the Czech Authorities focus mostly on general surveillance of commercial GM crops, using the established surveillance networks and practices such as monitoring of agricultural plants, variety/seed registration, plant health and environmental observations.
The general surveillance includes observation of:
- changes in fitness, survival and dissemination of GM plants,
- interaction between GM plant and non-target organisms, e.g. direct/indirect impact on non-target organisms, changes in susceptibility to non-target pests and diseases;
- impact on habitat diversity and biodiversity, including surrounding area,
- and others.
The State Phytosanitary Administration, Central Institute for Supervising and Testing in Agriculture and Czech Environmental Inspectorate observe potential effects of cultivation of GM maize as a part of their general activities (phytosanitary care, agricultural supervision, nature protection etc.). The Ministry of Environment is currently identifying environmental programmes that can be used for the general surveillance as well.
More information on post-market monitoring activities in the Czech Republic can be retrieved from the Czech node of the BCH at http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/other_resources.html.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • Yes
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • Yes
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • Yes
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
Question 103:
Article 14 of Regulation (EC)1946/2003 that is directly applicable in the Czech Republic) provides for measures to prevent unintentional transboundary movements of GMOs and appropriate responses, including emergency measures.

Conventional maize seeds, which was later proved to contain traces of unauthorized GM maize, was transported to the Czech Republic from other European country in 2009 and 2010. However, this transfer within the European Union cannot be considered as a transboundary movement according the relevant EU legislation - Regulation (EC)1946/2003 states that "transboundary movement" means the intentional or unintentional movement of a GMO between one Party or non-Party and another Party on non-Party, excluding intentional movements between Parties within the Community.
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • Yes
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • Yes
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes
114. Has your country established procedures for the sampling and detection of LMOs?
  • Yes
115. Here you may provide further details on the implementation of Article 18 in your country:
The Czech Republic follows the EU comprehensive legal framework on GMOs, which also addresses the issues of handling, transport, packaging and identification requirement covered by Article 18. The parallel EU 2nd National Report lists the adopted legal acts and measures that are of direct relevance to the implementation of Article 18.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
123. Here you may provide further details on the implementation of Article 19 in your country:
The Czech Republic has designated its own competent autority and a national focal point (NFP), while the EU have also designated its own competent authorities and NFP.
Close cooperation and information sharing exists between EU nad the Czech Republic as well as other Member States.
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available and in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available and in the BCH
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information available and in the BCH
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information available but not in the BCH
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information available but not in the BCH
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information available but not in the BCH
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information available and in the BCH
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • No
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
128. Has your country experienced difficulties accessing or using the BCH?
  • Yes
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Yes
130. Is the information submitted by your country to the BCH complete and up-to date?
  • Yes
131. Here you may provide further details on the implementation of Article 20 in your country:
Question 124 i: Only final decisions on field trials were made in the Czech Republic. Final decisions on commercial release are made on EU level and are available at the EU BCH.
Questions 124 j: Information  according to Article 14, paragraph 4 published at the European level in the EU BCH is valid also for the Czech Republic.
Question 124 k, l: Decisions according to the Article 11, paragraph 1 are taken at the European level and are obligatory also for the Czech Republic. All these decisions are made available in the EU BCH.
Questions 124 m: Article 11, paragraph 6 is not relevant for the Czech Republic as it is not a developing country or Party with an economy in transition.
Question 126: One person was appointed the BCH National Focal Point and Cartagena Protocol National Focal Point in the Czech Republic. This person also works for the Czech competent authority under the Cartatena Protocol on Biosafety.
Question 128: Minor difficulties with the BCH Central Portal were experienced and consulted with the Secretariat during the current reporting period. Communication with the BCH team was quick and helpful, great assisstance was always provided and therefore all problems were promptly solved.    
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • Yes, always
134. Here you may provide further details on the implementation of Article 21 in your country:
Act 78/2004 Coll., paragraph 9 as well as relevant European legislation, which is listed in the parallel EU 2nd National Report, define which information can be treated as confidentional.

In addition, it has to be noted that all the confidentialy provisions make clear what information shall never be considered as confidential, notably as regards the general description of the GMO, the name and address of the authorisation holders, the risk assessment  information and any methods and plans for emergency responses.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Multilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
138. If you answered Yes to question 137, how were these resources made available?
  • Regional channels
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • No
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Identification of LMOs, including their detection
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Technology transfer
  • Identification of LMOs, including their detection
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • No
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • Yes
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
GEF approved in 2005 the last support for the Czech Republic for the Project (2006 - 2011) aiming at implementation of the National Biosafety Framework (NBF). This Project  represented an important contribution to the  NBF in the Czech Republic, in all important areas: biosafety policy; regulatory regime; administrative system; monitoring and enforcement; public awareness, participation and education. Capacity building formed an integral part of activities developed within the Project.
Further capacity-building activities were developed in the Czech Republic within regional and subregional workshops (e.g. in cooperation with FAO for CEE countries, UNEP instruction workshops etc.) 
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
152. Has your country established a biosafety website?
  • Yes
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • Yes
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • Yes
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • More than 5
160. Here you may provide further details on the implementation of Article 23 in your country:
Czech legislation on GMOs promotes public awareness and participation as an integral part of its regulatory framework. Act 78/2004 Coll., as later amended that is in line with relevant Community law governing GMOs, and in particular Directive 2001/18/EC and Regulation (EC) No 1829/2003, incorporates following provisions for public participation in decision-making on GMOs:
▪ The Ministry of the Environment of the Czech Republic makes available a summary of the notification for deliberate release of GMO into the environment for experimental purposes  to the public on the internet, on its official board and ensures its publication by the relevant municipality and regional authorities. Anybody may send to the Ministry his/her opinion or make comments within 30 days of publication of the summary of the notification. In case that a negative opinion/comments from the public is raised, in which environmental risk assessment results are doubted or an objection to insufficient protection of the health and the environment is made, the Ministry is obliged to arrange public hearing prior to making a decision.
▪ The Czech Republic makes available to the public online information in Czech language on the  use of GMOs at http://www.mzp.cz/cz/geneticky_modifikovane_organismy. Up-to-date information on the contained use as well as all intentional releases of GMOs into the environment in their territory is available - the Register of  authorized GMOs and the Register of GMO Users were established and made public here. Information on GMOs  approved to be placed on the market are also made available to the public - European databases and its relevant links are provided. Detailed information on system of exchange of information established in the EU is provided in the parallel EU 2nd National Report.

Furthemore, cooperation has been developed with centres of environmental education, schools, civil society and other organizations, especially within the UNEP/GEF Project, and public awareness and education have been enhanced through numerous workshops and edited publications.  Internet represent an important source of information (web-pages of the Ministry of the Environment, Ministry of Agriculture, research and other institutions).

The Czech node of the BCH Central Portal  http://www.mzp.cz/biosafety was established with support of the UNEP-GEF project "Building Capacity for Effective Participation in the Biosafety Clearing-House" (2006-2008). Besides obligatory information according to Article 20 much useful non-obligatory information on the use of GMOs and relevant activities in the Czech Republic is provided.

Moreover, the Czech Republic is Party to the Aarhus Convention on Access to Information , Public Participation in Decision-making and Access to Justice in Environmental Matters. The main legal instrument to align EU Member States legislation with the provisions of the Aarhus Convention is listed in the parallel EU 2nd National Report. In the Czech Republic, access to information is regulated by Act 123/1998 Coll., on Right to Environmental Information  and Act 106/1999 Coll., on Free Access to Information. Acts transpose relevant above mentioned EU legislation.
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
167. Here you may provide further details on the implementation of Article 24 in your country:
Act 78/2004 Coll. and its implementing Decree 209/2004 Coll., which are in line with the EU legislation on GMOs, apply also to all imports / exports of LMOs, whether these originate from parties or non-parties to the Protocol.
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • Yes
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
Czech Republic follows EU legislation relevant to Article 25, which is listed in the parallel EU 2nd National Report.

No illegal transboundary movements have been recorded during the current reporting period.  Besides general provisions applied, the Czech Environmental Inspectorate monitored possible occurrence of  non-approved transgenic fish Danio rerio (so called Glow fish) that was found in the Czech Republic in 2006 and first half of 2007. However, no more above mentioned transgenic fish occurrence was recorded.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • Yes, to a limited extent
178. Here you may provide further details on the implementation of Article 26 in your country:
Socio-economic considerations have been relevant at Member State level for the question of co-existence between conventional, organic and GM crops. The Czech Republic adopted its national rules for co-existence in 2006 (Decree 89/2006 on detailed conditions for growing of genetically modified variety, amended by Decree 58/2010 Coll.) that are in line with the Commission Recommendation of July 23, 2003 on guidelines for the development of national strategies and best practices to ensure the coexistence of genetically modified crops with conventional and organic farming (notified under document C2003/556/EC.

The Czech Republic participated in discussions and information exchange on socio-economic issues at several international meetings, e.g. Network Group for the Exchange and Coordination of Information "COEX-NET" (working group under the European Commission).  The meetings serve for exchange and coordination of information concerning coexistence of genetically modified, conventional and organic crops. More information can be retrieved from http://ec.europa.eu/agriculture/gmo/coexistence/index_en.htm.

The Czech Republic also participated in the survey of the European Commission in 2009 and elaborated a report on the socio-economic implications of GMO cultivation. The Czech report is available at the Czech node of the BCH at
http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/other_resources.html
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • Yes
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • Yes
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
The Czech Republic signed the new treaty on 11 May 2011.
Upon signing the Supplementary Protocol the Czech Republic launched the ratification process. The new treaty has to be approved by the Parliament of the Czech Republic and afterwards signed (ratified) by the Head of the State.
A request for approval of the Supplementary Protocol was submitted to the Czech Parliament in July 2011.
Issues of liability and redress under the Supplementary Protocol are already covered by relevant domestic and EU legislation. For this reason it seems that no further legislation will be needed to implement the provisions of the Supplementary Protocol once it enters into force. However, conclusion of the Protocol requires the consent of the European Council and the European Parliament. The necessary administrative procedures thereto have recently been initiated.
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes, First report only
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • Lack of relevant information at the national level
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
No further comments.
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
The offline format is not very user friendly.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2001 or earlier
Here you may provide further details
The Czech Republic mobilized ca 19,485 USD to support implementation of the Cartagena Protocol in the last four years. This funding was used for the implementation of the Protocol mainly on national level.
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 1 per year or more
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • No
Here you may provide further details
The Czech Republic had in place a functional national mechanism for coordinating biosafety capacity building initiatives and activities for the UNEP/GEF projects implementation in the period from 2002 to 2011. At present, the mechanism is not active due to serious budgetary cuts at national level.
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 5,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • Yes
Here you may provide further details
Every year, the Ministry of the Environment allocates funding for building capacity for the implementation of the Protocol on the basis of an official request submitted by the National Focal Point. However, amount of funding strictly relies on the budget available for the implementation of all multilateral environmental agreements which the Czech Republic is a Party. Last four years, the Czech Republic allocated for above mentioned activities 4 - 5 000 USD per year.
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • Yes
Survey 9.b) Risk management
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs, which also addresses risk assessment and risk management.    The European guidance documents for the purpose of conducting risk assessment and risk management are listed and described in the parallel report of the European Union.
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs, which also addresses risk assessment and risk management.    The European guidance documents for the purpose of conducting (and so evaluating) risk assessment and risk management are listed and described in the parallel report of the European Union.
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs, which also addresses risk assessment and risk management.   The details are listed and described in the parallel report of the European Union.
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • Yes
Here you may provide further details
The Competent Authority handling the notifications and regulating the use of GMOs in the Czech Republic is the Ministry of the Environment of the Czech Republic (Competent Authority under EU Directives 2001/18/EC and 2009/41/EC). It co-operates with the Ministry of Health as regards risks for human health and with the Ministry of Agriculture as the agricultural risk, animal health, crops and feeds are concerned. An expert advisory body to the Ministry of the Environment, the Czech Commission for the Use of GMOs and Genetic Products, consists of scientists, representatives of administrative authorities and NGOs and was established in 2001.  The activities of the Commission cover the risk assessment and review of the risk assessment provided by the notifier of contained use, deliberate release into the environment and placing on the market of genetically modified organisms and products containing or consisting of genetically modified organisms, including the export and import thereof.  Summaries of risk assessment are available at BCH.
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • No
Here you may provide further details
As to monitoring of LMOs authorised for placing on the market, due to limited financial and personal capacities, the Czech Authorities focus mostly on general surveillance of commercial GM crops, using the established surveillance networks and practices such as monitoring of agricultural plants, variety/seed registration, plant health and environmental observations.
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs and safe transport of dangerous goods, which also addresses the safe handling, transport, and packaging of living modified organisms.    The European guidance documents for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms are listed and described in the parallel report of the European Union.
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • Yes
Here you may provide further details
Socio-economic considerations are taken into account when making decision about field trials only as a part of risk management measures (isolation distance) in the Czech Republic.  As to GMOs for commercial use, socio-economic considerations have been relevant at national level for the question of co-existence between conventional, organic and GM crops. The Czech Republic adopted its national rules for co-existence in 2006 - Decree 89/2006 Coll., on detailed conditions for growing of genetically modified variety, amended by Decree 58/2010 Coll.  The detail information on the issue of socio-economic considerations in the EU is described in the parallel report of the European Union.
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • 10 or more
Here you may provide further details
In order to prepare the report on socio-economic impacts of GMO cultivation in Europe, the Czech Republic contributed by the national report about the socio-economic implications of the placing on the market of GMOs for cultivation and the report referred to 15 peer-reviewed published materials.  (http://www.mzp.cz/www/webdav_biosafety.nsf$files/Biosafety/pdf/Report%20on%20socioeconomic%20aspects.pdf; http://ec.europa.eu/food/food/biotechnology/reports_studies/docs/Czech_contribution_en.pdf)  The Czech Republic also participated in the international workshop on socio-economic impacts of GM crops, organised by the Joint Research Centre of the Commission (JRC) and the Food and Agriculture Organisation of the United Nations (FAO) in November 2011.
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
No experience in taking socio-economic considerations into account in LMO decision making. When making decision about field trials, socio-economic considerations are applied only as part of risk management measures (isolation distance).
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs, which also addresses the unintentional release of living modified organisms. Further details on this legal framework are listed and described in the parallel report of the European Union.  The Ministry of the Environment is the Competent Authority and the focal point for the Cartagena Protocol on Biosafety and for the EC Regulation No 1946/2003 on transboundary movements of genetically modified organisms as well. Regulation No 1946/2003 covers exports of GMOs to third countries and unintentional movements of GMOs. Article 14 of Regulation 1946/2003 provides for measures to prevent unintentional transboundary movement of GMOs and appropriate responses, including emergency measures.  The Competent Authority on state supervision of the use of GMOs is the Czech Environmental Inspectorate. It co-operates with other state supervision bodies in fulfilling this task:  • Czech Agriculture and Food Inspection Authority in charge of food inspections and control;  • Central Institute for Supervising and Testing in Agriculture in charge of seeds and feed;  • State Veterinary Administration as to animal related supervision;  • State Institute for Drug Control as medicinal products are concerned;  • Customs Administration in charge of export and import.
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • 50 or more
Survey 19.b) Monitoring
  • 10 or more
Survey 19.c) Management / Control
  • 50 or more
Here you may provide further details
As set up by the Czech Act No. 78/2004 Coll., on Genetically Modified Organisms and Genetic Products, the Ministry of the Environment established its expert advisory body - The Czech Commission for the Use of Genetically Modified Organisms and Genetic Products, consisting of scientists, representatives of administrative authorities and NGOs.  All the members of this expert advisory body have been trained in issue of LMOs in various fields of study including risk assessment, monitoring, management, control and identification of LMOs.  There is also number of officials from supervision authorities, other scientists from Czech universities, GMO laboratory personnel and professional consultants who worked in field of GMO for many years and have been trained to a various extent in risk assessment, monitoring, management and control of LMOs.
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • Yes
Here you may provide further details
The Czech Environmental Inspectorate is the main Competent Authority on state supervision of the use of LMOs.  It cooperates with other state supervision bodies responsible for different areas: Czech Agriculture and Food Inspection Authority in charge of food inspections and control; Central Institute for Supervising and Testing in Agriculture in charge of seeds and feed; State Veterinary Administration as to animal related supervision; State Institute for Drug Control as medicinal products are concerned; Customs Administration in charge of export and import; Regional Agricultural Agencies of the Ministry of Agriculture in charge of field control of crop cultivation (compliance with coexistence rules).  Five authorized detection laboratories are available for these Authorities.
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs, which also addresses risk assessment and risk management.  The Czech Republic is using among others EU training material and/or technical guidance, which are listed in the parallel report of the European Union, for training in risk assessment and risk management of LMOs.
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • Yes
Survey 22.b) Effective
  • Yes
Here you may provide further details
There is important to note that in the process of time there is always the need to follow new development in the field of LMOs, risk assessment and risk management and keep the materials and guidance up to date.
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • None
Here you may provide further details
Custom officers in the Czech Republic act according the provisions of the Act No. 78/2004 Coll., on the Use of Genetically Modified Organisms and Genetic Products. No specific training to custom officers has been organized yet. The issue of GMO import, export and transit will be covered by the certificated course which is planned for September 2013.
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • 10 or more
Here you may provide further details
All personnel of the authorised laboratories for detection LMOs in the Czech Republic have received training in detection of LMOs. Besides authorised laboratories, there is definitely number of other laboratory personnel, which is trained in the detection of LMOs (methods based on a classic and Real Time PCR).
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • Yes
Here you may provide further details
Laboratories cooperating on the basis of contracts with the Ministry of the Environment are the laboratory of the Department for Food Safety and Nutrition of the National Institute of Public Health (charged by monitoring genetically modified organisms in food and  commodities, belonging to the Ministry of Health), The National Reference Laboratory for GMOs Testing and DNA Fingerprinting of the Crop Research Institute, Prague (focused on the detection and determination of genetic modification in plants and derived products), and the Controlling Laboratory of the Department of Biochemistry and Microbiology of the Institute of Chemical Technology, Prague (concentrated on detection and quantification of plant genetic modifications).  There are two more laboratories which are available for supervision authorities. The first is the laboratory of the Central Institute for Supervising and Testing in Agriculture, an institution of the Ministry of Agriculture, which is in charge of controlling seeds and feed. The second is the State Veterinary Administration in Jihlava, which is a supervision institution under the Ministry of Agriculture and it is responsible for inspection of genetically modified organisms of animal origin.  All described laboratories are officially accredited and they regularly participate in inter-laboratory tests. Their equipment with modern technique enables use of internationally recognized methods based on a classic and Real Time PCR, accompanied with other techniques, e.g. unified sampling and homogenization of samples before analysis. All these laboratories are regular members of the European Network of GMO Laboratories since the accession of the Czech Republic to the European Union (May 2004).
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • 5 or more
Here you may provide further details
See the question 25.
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • 5 or more
Here you may provide further details
All of certified laboratories for LMO detection in the Czech Republic are operational.
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • No
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
The Czech Republic, a member of the European Union, follows the EU comprehensive legal framework on GMOs, which also addresses response measures for damage to biodiversity resulting from living modified organisms.  The Act No. 167/2008 Coll., on prevention and remedying environmental damage and amendement on some laws transposes the Directive 2004/35/CE of the European Parliament and of the Council of April 21, 2004, on environmental liability with regard to the prevention and remedying of environmental damage. The Act covers, inter alia, environmental damage resulting from living modified organisms.  The Czech Republic has also ratified the Nagoya - Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety on February 13, 2012.
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Here you may provide further details
The Czech Republic has integrated the system for informing the public and modalities for public participation in the decision-making process regarding LMOs into Act No. 78/2004 Coll., on Genetically Modified Organisms and Genetic Products.  After receiving the notification the Ministry of the Environment (MoE) makes a summary of the notification available to the public on the internet (website of MoE - http://www.mzp.cz/cz/informace_o_zahajeni), issue a notice about it on the official board and on the internet official board of the Ministry and ensures its publication by the relevant municipality and regional authorities, where the deliberate release or contained use is intended. And also in the case of field trials the summary of the notification is also made available to the European Commission and other EU Member States by entering the data into JRC WebSNIF database http://gmoinfo.jrc.ec.europa.eu/.  If the MoE receives negative opinion/comments from the public, in which environmental risk assessment results are doubted or an objection to insufficient protection of the health and the environment is made, the MoE is obliged to arrange public hearing prior to making a decision.  MoE draw up a record and a complete audio record of the public hearing containing particularly the information on participation and conclusions of the consultation and make it available to the public on its website. Any final decision on authorisation always contains a detailed settlement of all received opinions and comments and also the results of the public hearing.
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • National website
  • Public hearings
  • biosafety related publications
Survey 32. If you indicated multiple modalities for public participation in the question above, which one was most used?
indicator 2.5.2
  • National website
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • 5 or more
Here you may provide further details
Biosafety related issues, education and courses are included in the relevant fields of study (e.g. various branches of biology, ecology, agronomy, biochemistry) at academic institutions.
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • 5 or more
Here you may provide further details
Biosafety training materials are available e.g. at academic institutions, which are offering biosafety education and training courses and programmes.
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • Yes
Survey 35.b) Enforcement system
  • Yes
Here you may provide further details
The Czech Environmental Inspectorate is the main Competent Authority on state supervision of the use of LMOs.  It cooperates with other state supervision bodies responsible for different areas: Czech Agriculture and Food Inspection Authority in charge of food inspections and control; Central Institute for Supervising and Testing in Agriculture in charge of seeds and feed; State Veterinary Administration as to animal related supervision; State Institute for Drug Control as medicinal products are concerned; Customs Administration in charge of export and import; Regional Agricultural Agencies of the Ministry of Agriculture in charge of field control of crop cultivation (compliance with coexistence rules).  The activity of the Czech Environmental Inspectorate (CEI) in the field of GMOs is defined by the Act No. 78/2004 Coll., on the Use of Genetically Modified Organisms and Genetic Products. CEI is the competent Authority for remedial measures in case of a breach of the law and penalisations for offences. Regional Inspectorates of the CEI control the institutions using genetically modified organisms in the regime of contained use both for research and production, field trials and commercial GM crops cultivation in close collaboration with the Regional Agriculture Agencies, in case of placing on the market in close collaboration with the institutions of Ministry of Agriculture and Ministry of Health. CEI inspectors may enter the plots, premises and facilities used(or supposed to be used) for handling with genetically modified organisms or GM products in case of necessity, to take samples and to control the compliance with the rules, handling conditions and the documentation. For the detection and quantification of the contents of genetically modified organisms, CEI is using contracted and certified laboratories.
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • 10 or more
Here you may provide further details
The Czech Republic organized at least 10 events since 2011, e.g.:  - annual meeting of representatives of EU supervision body authorities - European Enforcement Project (May 2013);  - The Eighth Coordination Meeting for Governments and Organizations Implementing or Funding Biosafety Capacity-Building Activities (March 2012);  - The Ninth Meeting of the Liaison Group on Capacity-Building for Biosafety (March 2012)  - workshop - International Biosafety Negotiations and New Treaty on Liability and Redress (May, 2011)  - 3 public hearings of the Czech Commission for the Use of Genetically Modified Organisms and Genetic Products (annually);  - public seminars on GMO issues at Czech universities (several per year).
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • 10 or more
Here you may provide further details
The Czech Republic has made available biosafety related publications, such as:  - Říha, K., Křístková, M., 2012. Aktuální přehled využití geneticky modifikovaných plodin (GMP) v zemědělství a výzkumu v EU a třetích zemích, s přihlédnutím k socio-ekonomickým dopadům GMP. Ministerstvo životního prostředí, 35. (http://www.mzp.cz/C1257458002F0DC7/cz/publikace_gmo/$FILE/oeres-GM_plodiny_prehled-20130425.pdf);  - Stratilová, Z., 2012. GMO BEZ OBALU. Ministerstvo zemědělství, Praha, 31.  ( http://eagri.cz/public/web/file/209381/GMO_web_aktual_listopad_12.pdf).    There are also scientific articles made available in scientific journals, such as:  - Svobodová, Z., Habuštová, O., Sehnal, F., Holec, M., Hussein, H. M., 2013. Epigeic spiders are not affected by the genetically modified maize MON 88017. Journal of Applied Entomology 137: 56-67. ( http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0418.2012.01727.x/abstract;jsessionid=C9F3315C7F00AD9D80FA37457484A9BD.d04t03);  - Habuštová, O., Doležal, P., Spitzer, L., Svobodová, Z., Hussein, H., Sehnal, F., 2012. Impact of Cry1Ab toxin expression on the non-target insects dwelling on maize plants. Journal of Applied Entomology. ( http://onlinelibrary.wiley.com/doi/10.1111/jen.12004/abstract).
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • national websites of authorities - Ministry of the Environment, Ministry od Agriculture; scientific journals
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • None
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • No
Here you may provide further details
The Czech Republic participate in some research programmes on the biosafety of GMOs, which are listed and described in the parallel report of the European Union.
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • No
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • 10 or more
Here you may provide further details
The number of educational materials is stated for the last 5 years for the Czech Republic and it comprises materials in Czech and English language. Many of the materials were created during the UNEP/GEF projects - Implementation of the Draft National Biosafety Framework for the Czech Republic (2006 - 2010) and Add-on Project - Building Capacity for Effective Participation in the Biosafety Clearing House (2006 - 2008).  There are also a lot of available and used educational materials on biosafety published by the EU.